3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
32
Unknown
24
Recruiting
14
Terminated
6
Withdrawn
3
Not yet recruiting
3
Active not recruiting
3
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
33
Neoplasms
28
Colorectal Neoplasms
19
Prostatic Neoplasms
17
Lung Neoplasms
13
Leukemia, Myeloid, Acute
12
Glioblastoma
12
Stomach Neoplasms
10
Head and Neck Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pancreatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Melanoma
8
Glioma
8
Brain Neoplasms
8
Rectal Neoplasms
7
Ovarian Neoplasms
7
Carcinoma, Hepatocellular
7
Neoplasm Metastasis
6
Hematologic Neoplasms
6
Uterine Cervical Neoplasms
5
Polycystic Ovary Syndrome
5
Multiple Myeloma
5
Esophageal Neoplasms
5
Carcinoma, Renal Cell
5
Triple Negative Breast Neoplasms
4
Sarcoma
4
Myelodysplastic Syndromes
4
Lymphoma, B-Cell
4
Lymphoma
4
Interventions
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
OTHER
×
Drug-Related Side Effects and Adverse Reactions
×
Clear all
NCT04824352
2024-05-14
AIEO
Peking University People's Hospital
Phase 2
Suspended
44 enrolled